MBX vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

MBX

59.1
AI Score
VS
MBX Wins

ZBIO

49.6
AI Score

Investment Advisor Scores

MBX

59score
Recommendation
HOLD

ZBIO

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MBX ZBIO Winner
Net Income -60.61M -377.74M MBX
Operating Income -68.20M -383.06M MBX
ROE -14.8% -156.0% MBX
ROA -13.9% -98.5% MBX
Total Assets 435.91M 383.64M MBX
Cash 54.12M 110.64M ZBIO
Current Ratio 18.08 5.61 MBX
Free Cash Flow -44.17M -172.35M MBX

Relative Price Performance (Last 90 Days)

MBX 1M: -12.8% · 3M: -18.6% ZBIO 1M: -4.7% · 3M: -7.1%

Current Technical Phase

MBX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 39

RSI (14): 38.9 · Price: $50.46

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.4 · Price: $28.23

Fundamentals Snapshot

Metric MBX ZBIO
Market Cap — —
Forward P/E -12.7 -6.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin — -212.5%
Operating Margin 0.0% -77.7%
EPS -2.37 -9.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MBX is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.